Found 78 clinical trials
Sanofi Test Website No-Image
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum et sapien non purus accumsan pulvinar eget ac tortor. Ut et sagittis libero, nec vestibulum quam. Aliquam non felis consectetur libero vestibulum tincidunt vitae in est.
- 0 views
- 08 Jul, 2024
MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM
This trial is an adaptive platform trial. The structure of the protocol allows the trial to evolve over time. Multiple investigational arms will be included within the trial under a Master Protocol (MP). These investigational arms may be added as appendices at different times depending on whether they are trial-ready …
- 0 views
- 31 Jul, 2025
- 8 locations
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID-19.
- 0 views
- 23 May, 2025
- 22 locations
VTP-1000 in Adults with Celiac Disease
GLU001 is a first-in-human clinical trial to assess the safety and tolerability of VTP-1000 for adults with celiac disease. This trial will assess VTP-1000 at various dose levels compared to placebo in a single ascending dose (SAD) and multiple ascending dose (MAD) format. Participants will be followed for a short …
- 0 views
- 12 Jun, 2025
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD) (ASCEND)
The primary objective of this study is to evaluate the safety and tolerability of a single dose of INS1201 via IT administration in ambulatory male participants with DMD.
- 0 views
- 24 Jun, 2025
- 3 locations
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderate-to-severe AD who have completed treatment in an APG777 Parent Study (NCT06395948).The LTE study will consist of 3 periods: 1) Screening Visit will coincide with the last visit of …
- 0 views
- 22 Jul, 2025
- 12 locations
A Phase I Study of SNH-119014 in Healthy Volunteers
SNH-119014 is an oral small-molecule agonist of pyruvate kinase red blood cell isozyme (PKR) being developed for the treatment of hemolytic anemias. This initial study will characterize the safety, tolerability and the pharmacokinetics/pharmacodynamics (PK/PD) of a single ascending dose and multiple ascending doses of SNH-119014 in the context of Phase …
- 0 views
- 31 Jul, 2025
- 1 location
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis. We plan to compare the ability of three demensional-magnetic resonance elastography (3D-MRE) to two demensional-magnetic resonance elastography (2D-MRE) …
- 0 views
- 17 Aug, 2025
- 6 locations
Medium-term Effects of Treatments in Autoimmune Encephalitis (META)
Autoimmune encephalitides are severe neurological disorders requiring urgent treatment, even though there is no standard guideline by lack of empirical evidence. Commonly used treatments are divided into so-called first-line (steroids, intravenous immunoglobulins, plasma exchanges) and second-line (rituximab, cyclophosphamide, tocilizumab, others), and may be used in association or sequentially. There is …
- 0 views
- 22 Aug, 2025
- 6 locations